HIGHLIGHTS
- who: BAG et al. from the Department of Experimental Research, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University have published the article: Theranostics 2023, Vol. 13, Issue, in the Journal: (JOURNAL)
- what: Ethical approval and patient consent were obtained from the Institutional Research Ethics Committee for the use of clinical specimens for research purposes. The study demonstrated that BAG2 serves as an oncogene that promotes and exacerbates the mutant p53 aggregates by recruiting HSP90, and consequently contributes to chemoresistance in breast cancer.
- how . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.